Inventor
James R. Pruitt
Inventor
Landenberg, PA, US
Overview
Patents· 24 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds48%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations11%
C08LCompositions of macromolecular compounds7%
G02BOptical elements, systems or apparatus7%
B29DProducing particular articles from plastics or from substances in a plastic state5%
C08GMacromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds5%
C09DCoating compositions, e.g. paints, varnishes or lacquers5%
A61KPreparations for medical, dental or toiletry purposes2%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
C08FMacromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds2%
PatentTitleYear
10,920,102Silicone hydrogel lens with a crosslinked hydrophilic coating202110,920,099Poly(meth)acrylamide-based copolymers with carboxyl-terminated pendant chains202110,913,224Ophthalmic devices for delivery of hydrophobic comfort agents20217,235,575'Guanidine mimics as factor Xa inhibitors'20077,141,596'Inhibitors of proteins that bind phosphorylated molecules'20066,962,935'Oxygen or sulfur containing heteroaromatics as factor Xa inhibitors'20056,958,356'Guanidine mimics factor Xa inhibitors'20056,949,546'N-ureidoheterocycloalkyl-piperidines as modulators of chemokine receptor activity'20056,906,070'Guanidine mimics as factor Xa inhibitors'20056,858,616'Nitrogen containing heterobicycles as factor Xa inhibitors'20056,627,629'N-ureidoheterocycloalkyl-piperidines as modulators of chemokine receptor activity'20036,602,895'Inhibitors of factor Xa with a neutral P1 specificity group'20036,569,874'Thiazoles as factor Xa inhibitors'20036,548,512'Nitrogen containing heteroaromatics as factor Xa inhibitors'20036,426,346'6-membered aromatics as factor Xa inhibitors'20026,413,980'Nitrogen containing heterobicycles as factor Xa inhibitors'20026,403,620'Inhibitors of factor Xa with a neutral P1 specificity group'20026,339,099'Guanidine mimics as factor Xa inhibitors'20026,187,797'Phenyl-isoxazoles as factor XA Inhibitors'20016,060,491'6-membered aromatics as factor Xa inhibitors'20006,020,357'Nitrogen containing heteroaromatics as factor Xa inhibitors'20005,998,424'Inhibitors of factor Xa with a neutral P1 specificity group'19995,939,418'Isoxazoline, isothiazoline and pyrazoline factor Xa inhibitors'19995,310,929'Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists'1994Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1994–2007Based in Landenberg, PA, US· patent location history
1999–2002Patents assigned to DU PONT PHARM CO (5)· patent assignee history
2002–2005Patents assigned to BRISTOL MYERS SQUIBB PHARMA CO (8)· patent assignee history
2003–2007Patents assigned to BRISTOL MYERS SQUIBB CO (3)· patent assignee history
2021Patents assigned to ALCON INC (3)· patent assignee history
2021Patents assigned to NOVARTIS AG (3)· patent assignee history
2021Based in Suwanee, GA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRISTOL MYERS SQUIBB PHARMA CO | 8 | 2002–2005 |
| DU PONT PHARM CO | 5 | 1999–2002 |
| ALCON INC | 3 | 2021 |
| BRISTOL MYERS SQUIBB CO | 3 | 2003–2007 |
| NOVARTIS AG | 3 | 2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| Landenberg, Pennsylvania, US | 21 | 1994–2007 |
| Suwanee, Georgia, US | 3 | 2021 |